Literature DB >> 27638537

[Minutes of the AG Knochen-, Gelenk- und Weichgewebspathologie : DGB-Conference on 19 May 2016].

S Scheil-Bertram1, V Krenn2.   

Abstract

Year:  2016        PMID： 27638537     DOI： 10.1007/s00292-016-0193-5

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  17 in total

Review 1.  Hox collinearity - a new perspective.

Authors:  Antony J Durston; Hans J Jansen; Paul In der Rieden; Michiel H W Hooiveld
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

2.  EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.

Authors:  Siwen Hu-Lieskovan; Jingsong Zhang; Lingtao Wu; Hiroyuki Shimada; Deborah E Schofield; Timothy J Triche
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

Review 3.  Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.

Authors:  Claudia Maria Hattinger; Massimo Serra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-06-25       Impact factor: 4.481

4.  In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients' shorter overall survival.

Authors:  Adrian von Witzleben; Lukas T Goerttler; Jochen Lennerz; Stephanie Weissinger; Marko Kornmann; Regine Mayer-Steinacker; Alexandra von Baer; Markus Schultheiss; Peter Möller; Thomas F E Barth
Journal:  Eur Spine J       Date:  2015-09-23       Impact factor: 3.134

Review 5.  The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration.

Authors:  Eleftherios A Makris; Pasha Hadidi; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2011-07-18       Impact factor: 12.479

6.  Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.

Authors:  Florian Haller; Jasmin Knopf; Anne Ackermann; Matthias Bieg; Kortine Kleinheinz; Matthias Schlesner; Evgeny A Moskalev; Rainer Will; Ali Abdel Satir; Ibtihalat E Abdelmagid; Johannes Giedl; Roman Carbon; Oliver Rompel; Arndt Hartmann; Stefan Wiemann; Markus Metzler; Abbas Agaimy
Journal:  J Pathol       Date:  2016-04       Impact factor: 7.996

Review 7.  Advances in emerging drugs for osteosarcoma.

Authors:  Claudia Maria Hattinger; Marilù Fanelli; Elisa Tavanti; Serena Vella; Stefano Ferrari; Piero Picci; Massimo Serra
Journal:  Expert Opin Emerg Drugs       Date:  2015-06-01       Impact factor: 4.191

8.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Authors:  Sam Behjati; Patrick S Tarpey; Nadège Presneau; Susanne Scheipl; Nischalan Pillay; Peter Van Loo; David C Wedge; Susanna L Cooke; Gunes Gundem; Helen Davies; Serena Nik-Zainal; Sancha Martin; Stuart McLaren; Victoria Goodie; Ben Robinson; Adam Butler; Jon W Teague; Dina Halai; Bhavisha Khatri; Ola Myklebost; Daniel Baumhoer; Gernot Jundt; Rifat Hamoudi; Roberto Tirabosco; M Fernanda Amary; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Adrienne M Flanagan
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

9.  Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.

Authors:  Marilù Fanelli; Claudia Maria Hattinger; Serena Vella; Elisa Tavanti; Francesca Michelacci; Beth Gudeman; Daryl Barnett; Piero Picci; Massimo Serra
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

10.  Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.

Authors:  Michal Kovac; Claudia Blattmann; Sebastian Ribi; Jan Smida; Nikola S Mueller; Florian Engert; Francesc Castro-Giner; Joachim Weischenfeldt; Monika Kovacova; Andreas Krieg; Dimosthenis Andreou; Per-Ulf Tunn; Hans Roland Dürr; Hans Rechl; Klaus-Dieter Schaser; Ingo Melcher; Stefan Burdach; Andreas Kulozik; Katja Specht; Karl Heinimann; Simone Fulda; Stefan Bielack; Gernot Jundt; Ian Tomlinson; Jan O Korbel; Michaela Nathrath; Daniel Baumhoer
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 17.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.